---
reference_id: "PMID:15711045"
title: Fistulizing Crohn's disease.
authors:
- Felley C
- Mottet C
- Juillerat P
- Froehlich F
- Burnand B
- Vader JP
- Michetti P
- Gonvers JJ
journal: Digestion
year: '2005'
doi: 10.1159/000083868
content_type: abstract_only
---

# Fistulizing Crohn's disease.
**Authors:** Felley C, Mottet C, Juillerat P, Froehlich F, Burnand B, Vader JP, Michetti P, Gonvers JJ
**Journal:** Digestion (2005)
**DOI:** [10.1159/000083868](https://doi.org/10.1159/000083868)

## Content

1. Digestion. 2005;71(1):26-8. doi: 10.1159/000083868. Epub 2005 Feb 4.

Fistulizing Crohn's disease.

Felley C(1), Mottet C, Juillerat P, Froehlich F, Burnand B, Vader JP, Michetti 
P, Gonvers JJ.

Author information:
(1)Division of Gastroenterology and Hepatology, Lausanne University Medical 
Center, Lausanne, Switzerland. Christian.Felley@hospvd.ch

Fistulas are common in Crohn's disease. A population-based study has shown a 
cumulative risk of 33% after 10 years and 50% after 20 years. Perianal fistulas 
were the most common (54%). Medical therapy is the main option for perianal 
fistula once abscesses, if present, have been drained, and should include 
antibiotics (both ciprofloxacin and metronidazole) and immunomodulators. 
Infliximab should be reserved for refractory patients. Surgery is often 
necessary for internal fistulas.

Copyright (c) 2005 S. Karger AG, Basel.

DOI: 10.1159/000083868
PMID: 15711045 [Indexed for MEDLINE]